Written Question·Department of Health and Social Care·UIN 191920
Clinical Trials
Tabled: 30 June 2023
Answered: 5 July 2023
Question
Rushanara Ali
Labour — Bethnal Green and Stepney
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency expedites human challenge trial applications where a case has gone beyond its 60-day review deadline.
Answer
The Medicines and Healthcare product Regulatory Agency (MHRA) is dealing with queued applications sequentially. However, the MHRA is reallocating work and routinely evaluates applications for their complexity and prioritises applications based on public h...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 191920) →